Literature DB >> 24500561

The function of heparanase in diabetes and its complications.

Fang Wang1, Andrea Wan1, Brian Rodrigues2.   

Abstract

Heparan sulfate proteoglycans are ubiquitous glycoproteins that contain several heparan sulfate polysaccharide side chains attached to a core protein. They function not only as a primary structural component of the extracellular matrix, but also provide a storage depot for bioactive molecules, such as basic fibroblast growth factor, vascular endothelial growth factor and lipoprotein lipase. Heparanase is an endoglycosidase that specifically hydrolyzes heparan sulfate into oligosaccharides. Recent studies have indicated that heparanase is engaged in the initiation and progression of diabetes, in addition to its associated complications. This review focuses on the participation of heparanase in the cleavage of heparan sulfate proteoglycans in pancreatic islets promoting beta cell death, promotion of atherosclerosis, and its role in cardiac metabolic switching in the early stage of cardiomyopathy during diabetes. Understanding the mechanisms by which heparanase is regulated in diabetes could provide a drug target to prevent diabetes and its complications.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  cardiomyopathie; cardiomyopathy; diabetes; diabète; heparanase; héparanase

Mesh:

Substances:

Year:  2013        PMID: 24500561     DOI: 10.1016/j.jcjd.2013.05.008

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  6 in total

Review 1.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

2.  Heparan Sulfate Mimicking Glycopolymer Prevents Pancreatic β Cell Destruction and Suppresses Inflammatory Cytokine Expression in Islets under the Challenge of Upregulated Heparanase.

Authors:  Ravi S Loka; Zhenfeng Song; Eric T Sletten; Yasmin Kayal; Israel Vlodavsky; Kezhong Zhang; Hien M Nguyen
Journal:  ACS Chem Biol       Date:  2022-06-04       Impact factor: 4.634

3.  A Genome-Wide Association Study of Prediabetes Status Change.

Authors:  Tingting Liu; Hongjin Li; Yvette P Conley; Brian A Primack; Jing Wang; Wen-Juo Lo; Changwei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

Review 4.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

5.  Anti-Diabetic Effects of Dung Beetle Glycosaminoglycan on db Mice and Gene Expression Profiling.

Authors:  Mi Young Ahn; Ban Ji Kim; Hyung Joo Yoon; Jae Sam Hwang; Kun-Koo Park
Journal:  Toxicol Res       Date:  2018-04-15

6.  Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome.

Authors:  Qingsong Wang; Xiu-Ling Zhou; Guang-Hai Mei; Jiantao Wang; Zhongyu Yu; Yue Hu; Xinyu Guo; Hanyu Zhang; Xiaodie Xu; Chengfeng He; Jingchun Guo; Yinghong Tao; Houguang Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-13       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.